Durham-based Immunotherapy firm Grid Therapeutics injects $4.5M funding – WRAL Tech Wire
WRAL Tech Wire |
Durham-based Immunotherapy firm Grid Therapeutics injects $4.5M funding
WRAL Tech Wire Grid Therapeutics, a Durham-based biotechnology company developing the first human derived targeted immunotherapy for cancer, has raised more than $4.5 million of a $5 million equity offering, according to a filing with the U.S. Securities and Exchange … Novartis Joins Harvard and Dana-Farber to Develop Delivery Systems for Immunotherapies |
